Phase II/III (Integrated)

392 trials 186 recruiting

Filter these 392 trials by condition, country, sponsor and more.

Open in Search →

Clinical trial for the treatment of COVID-19 and COVID-like illness in primary care Ended

2022-501707-27-01 COVID-like-illness 2024-10-03
Long-term Follow-up Study of Male Adults with Hemophilia B Previously Treated with Etranacogene Dezaparvovec (CSL222) Ended

2023-503765-37-00 Hemophilia B 2024-09-30
RElapse from Mrd Negativity As iNdication for Treatment Ended

2023-510215-18-00 Multiple myeloma 2024-09-26
Pilot study for the evaluation of [68Ga]Ga-PentixaFor PET imaging for the identification of unilateral adrenal secretion of ALdosterON in pa… Ended

2023-505507-22-00 Primary aldosteronism 2024-09-12
Effect of Dapagliflozin on myocardial and renal function following aortic valve stenosis intervention Ended

2024-514868-11-00 Aortic stenosis 2024-07-04
Evaluating T Cell Changes and Activation in Cancer Patient Using Two PET Tracers (iRelate) Ended

2023-509486-20-00 Breast cancer 2024-05-29
Effect of dimethyl fumarate administered to patients with adrenomyeloneuropathy: a multicenter, placebo controlled, phase IIb/III trial Ended

2023-506795-27-00 Adrenomyeloneuropathy 2024-04-15
Exploratory study of the expression of the serotonergic 5-HT4 receptor in Parkinson's disease Ended

2022-503089-57-00 Parkinson disease 2023-09-18
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen Ended

2022-500929-33-01 Human Immunodeficiency Virus (HIV-1) infection 2023-05-17
A study to test product setrusumab in subjects with brittle bone syndrome. Ended

2024-510919-29-00 Osteogenesis imperfecta (OI) 2023-05-08
A study in metastatic breast cancer patients receiving eftilagimod alpha or placebo in combination with a standard chemotherapy (paclitaxel) Ended

2024-511023-34-00 HER2-neg/low metastatic breast cancer 2023-05-05
A Trial to Evaluate the Long-term Safety and Tolerability of TAK-861 Ended

2023-508462-15-00 Narcolepsy with Cataplexy (Narcolepsy Type 1) 2023-04-27
PRODIGE 81-FFCD 2101-TRIPLET: Study evaluating the benefit of adding Ipilimumab to the combination of Atezolizumab and Bevacizumab in patien… Ended

2022-501217-31-00 Hepatocellular carcinoma 2023-03-09
A study to investigate the efficacy and safety of efgartigimod PH20 SC in adult participants with active idiopathic inflammatory myopathy Ended

2024-512785-33-00 Active Idiopathic Inflammatory Myopathy (IIM) 2023-03-01
Intralymfatisk immunterapi förstärkt av vitamin-D, en randomiserad placebokontrollerad studie och jämförelse med SLIT Ended

2024-515271-35-00 Allergisk Rinit 2023-02-01
Anti-PD-1 re-challenge after immune priming by ipilimumab and immune boosting by radiotherapy in advanced NSCLC. Ended

2022-500713-79-00 Patients with advanced NSCLC who have progressed after 2023-01-03
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Early… Ended

2024-515198-91-00 Dominantly Inherited Alzheimer Disease (DIAD) 2022-12-20
TACE-3: A two-arm multi-stage (TAMS) seamless phase II/III randomised trial of nivolumab in combination with TACE/TAE for patients with inte… Ended

2024-513882-38-00 Intermediate stage Hepatocellular carcinoma 2022-10-12
A randomized, placebo-controlled, double-blind, multi-center trial to assess efficacy and safety of octreotide subcutaneous depot (CAM2029) … Ended

2023-505313-24-00 Polycystic liver disease 2022-09-30
This study is to understand how well an investigational drug (called Napabucasin) works when given in combination with chemotherapy treatmen… Ended

2024-518205-17-00 Histologically or cytologically confirmed advanced panc 2022-05-27
Body surface area-based vs concentration-based dosing of cisplatin for hyperthermic intraperitoneal chemotherapy (HIPEC) in women with advan… Ended

2024-514711-99-00 FIGO stage III high grade serous ovarian cancer, perito 2022-05-02
A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular A… Ended

2023-506761-65-00 Spinal Muscular Atrophy (SMA) 2022-04-08
An international randomized clinical study, measuring safety and effectiveness of basimglurant for the treatment of pain in patients with Tr… Ended

2024-514497-41-00 Trigeminal neuralgia 2022-03-24
Efficacy of dalbavancin in osteoarticular infections associated with hip, knee and shoulder prostheses PRO-DALBA Ended

2024-518183-12-00 prosthetic joint infections 2022-03-07